Australia Stock Exchange release from CRESO PHARMA : Appendix 4G and Corporate Governance Statement
28/02/2022 05:34
Australia Stock Exchange release from CRESO PHARMA CPH.AX : Appendix 4G and Corporate Governance Statement
Recent news on Melodiol Global Health
See all newsBrief: Melodiol Global Health Reports Q1 Fy24 Unaudited Revenue Of A$4.8M
Brief: Melodiol Global Health Posts Group Unaudited H1 2024 Revenues Of A$9.3 Mln, Up 33%
Brief: Melodiol Global Health Seeks Trading Halt
Melodiol Global Health gains most in over 7 weeks on Canada asset sale
Brief: Melodiol Global Health Proposes A$12M Cash Asset Sale